La fase I de una vacuna conjugada frente a Salmonella Typhi y Paratyphi A se ha mostrado segura e inmunógena
De Coster I, Ghany M, Sarakinou E et al. Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial. Lancet Infect Dis published January 23, 2026 https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(25)00730-3/fulltext?dgcid=raven_jbs_aip_email La fiebre entérica causada por Salmonella enterica serovars Typhi y Paratyphi A…
